N

NeuroSense Therapeutics Ltd
D

NRSN

3.11000
USD
-0.35
(-10.12%)
مغلق
حجم التداول
34
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
5,899,365

العنوان: Neurosense Therapeutics Ltd

القطاع: الرعاية الصحية
الصناعة: Biotechnology
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.